Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000280005 represents an **antisense non-coding RNA transcript** overlapping or adjacent to the **DCHS2 locus**. Antisense transcripts are RNA molecules that are complementary to the sense mRNA of a gene and can influence gene expression through various mechanisms, including transcriptional interference, chromatin modification, and regulation of RNA stability[1][3]. There is a conserved biological effect of antisense transcription in altering the chromatin landscape near gene promoters and regulating the dynamics of sense RNA production, processing, and degradation[1][3]. However, specific molecular or physiological functions of this transcript in humans are not defined, and it is not recognized as a therapeutic or pharmacological target within current literature or drug databases. There is no evidence this transcript encodes a protein or has receptor/enzyme/transporter activity. In summary: ENSG00000280005 is a novel antisense non-coding RNA transcript to DCHS2, not a standard drug target or receptor, with insufficient data regarding functional, disease, or pharmacological roles[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to DCHS2 (ENSG00000280005).